All News
Filter News
Found 808,690 articles
-
Benitec Biopharma Provides Update on BB-301 Oculopharyngeal Muscular Dystrophy (OPMD) Program
9/16/2019
Benitec Biopharma (ASX: BLT, NASDAQ: BNTC), today announced their plans to complete three non-clinical studies that will facilitate the filing of an Investigational New Drug (IND) application and the formal initiation of a Phase I clinical trial in patients suffering from Oculopharyngeal Muscular Dystrophy (OPMD).
-
Association of Gaming Equipment Manufacturers (AGEM) and Gaming Laboratories International (GLI®) Donate $200,000 to Dr. Robert Hunter International Problem Gambling Center Through their Lasting Impact Philanthropic Initiative
9/16/2019
Through their joint charitable venture, the Lasting Impact Philanthropic Initiative, today the Association of Gaming Equipment Manufacturers (AGEM) and Gaming Laboratories International (GLI®) have committed $200,000 to the Dr. Robert Hunter International Problem Gambling Center over the next two years.
-
Rgenix Names Industry Veteran to Chief Medical Officer Role
9/16/2019
Robert Wasserman, MD, joins Rgenix with more than 20 years of oncology clinical development experience and prior senior roles in the biopharma industry
-
Elekta Awarded Sole Source Agreement With Premier
9/16/2019
Elekta (EKTA-B.ST) has been awarded a group purchasing agreement for Full Line Radiation Oncology Products and Services with Premier.
-
Bayer Names Daniella Foster New Head of Public Affairs and Sustainability for Consumer Health Division
9/16/2019
Bayer today announced Daniella Foster as the new Head of Public Affairs and Sustainability for the Consumer Health Division, effective September 16.
-
SWK Holdings to Present at the Fall Investor Summit
9/16/2019
SWK Holdings Corporation, a life science focused specialty finance company, announced that CEO Winston Black will present at the Fall Investor Summit being held in New York City.
-
Proton Therapy Coming to Kansas City with Opening of Provision CARES Proton Therapy Center
9/16/2019
Proton therapy precisely targets tumors thus reducing the risk of side effects and providing improved outcomes and quality of life for patients both during and after treatment.
-
Oncoheroes Biosciences Inc. and Boehringer Ingelheim International GmbH sign exclusive licensing agreement for volasertib
9/16/2019
Oncoheroes Biosciences Inc. ("Oncoheroes") and Boehringer Ingelheim International GmbH ("Boehringer Ingelheim") have signed a worldwide, exclusive licensing agreement for volasertib, an investigational anti-cancer compound that was originally discovered and developed by Boehringer Ingelheim
-
SwRI Offers Introductory Microencapsulation Workshop
9/16/2019
Southwest Research Institute is offering an “Introduction to Microencapsulation Workshop” October 7-8 at its headquarters in San Antonio.
-
New FDA Clearance Paves The Way to Optimization of Insulin Pump Therapy Across All Glucose Measurement Methods
9/16/2019
DreaMed Diabetes achieves unprecedented validation of Advisor Pro, its AI-based insulin recommendations technology
-
SkinTE Data Including Final Pilot Study Data Readout to be Presented at the Symposium on Advanced Wound Care Fall Meeting
9/16/2019
PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing and commercializing regenerative tissue products and biomaterials, today announced that four abstracts regarding the Company’s SkinTE™ product were accepted for poster presentations at the Symposium on Advanced Wound Care (SAWC) Fall Meeting in Las Vegas, which will be held from October 12-14, 2019.
-
Kineticos Prepares for Next Phase of Growth Expanding Its Senior Team
9/16/2019
Announces an expansion to the senior leadership team with the addition of Philip Gialenios, Chief Commercial Officer.
-
Shegerian & Associates: Nursing Director Fired After Raising Patient Safety Concerns At UCLA NICU
9/16/2019
A recently filed lawsuit alleges a pattern and practice of retaliation towards nurses at UCLA neonatal-intensive care units ("NICU").
-
BioLife Solutions Announces New evo® Cold Chain Customers
9/16/2019
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of a portfolio of best in class bioproduction tools for cell and gene therapies, today announced several new customers have adopted the evo cold chain management system in clinical trials targeting cancer and other leading causes of death.
-
Innoplexus Announces Appointment of Stratos Davlos as Chief Technology Officer (CTO) and Senior Vice President
9/16/2019
Mr. Davlos is a highly accomplished artificial intelligence and machine learning executive with over 20 years of leadership experience.
-
PharmaCyte Biotech Provides Information on Upcoming Shareholder Update Call
9/16/2019
The call is scheduled for Friday, September 20, 2019, commencing at 4:00 p.m. Eastern Daylight Time. The telephone number for the call is (515) 604-9056. The access code for the call is 195-864.
-
Intact Vascular to Announce One-Year Data from TOBA III Clinical Trial
9/16/2019
Study Investigates Use of the Tack Endovascular System® for Focal Dissection Repair Following Drug-Coated Balloon Angioplasty in PAD Patients
-
Varian Names Chief Medical Officer for Interventional Oncology
9/16/2019
Varian (NYSE: VAR) has named Francis R. Facchini, M.D., FSIR, as the new chief medical officer, Interventional Oncology, reporting to Dee Khuntia, Varian chief medical officer.
-
DiscGenics' U.S. Clinical Study of Cell Therapy for Disc Degeneration Passes Halfway Mark
9/16/2019
DiscGenics, Inc., a clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, today announced that the first 30 subjects have been safely treated its first-in-human U.S. clinical study of IDCT, an allogeneic, injectable disc cell therapy for mild to moderate degenerative disc disease (DDD
-
Bio-Techne Attains ISO 9001:2015 Certification for Fetal Bovine Serum Manufacturing Facility
9/16/2019
This certification demonstrates Bio-Techne's commitment for providing high-quality serum and media that aligns with the quality excellence standards preferred by biotech, biopharmaceutical and pharmaceutical companies as well as academic researchers.